Literature DB >> 16899596

Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.

Sergiu-Bogdan Catrina1, Ileana Ruxandra Botusan, Anja Rantanen, Anca Irinel Catrina, Pawan Pyakurel, Octavian Savu, Magnus Axelson, Peter Biberfeld, Lorenz Poellinger, Kerstin Brismar.   

Abstract

PURPOSE: Neoangiogenesis is essential for tumor development. Hypoxia-inducible factor (HIF), a transcriptional factor composed of two subunits (alpha and beta), plays a key role in this process, activating proangiogenic factors such as vascular endothelial growth factor (VEGF). The HIF alpha subunits are critically regulated by oxygen and are also modulated by growth factors. Kaposi sarcoma (KS) is a highly vascular tumor that releases large amounts of VEGF and for which we have recently described an essential role for the insulin-like growth factor (IGF) system. We therefore investigated the expression of HIF alpha subunits in biopsies from KS tumors and their modulation by IGF-I in KSIMM, a KS cell line.
RESULTS: Both HIF-1alpha and HIF-2alpha were expressed in KS biopsies in all tumoral stages. HIF-1alpha immunopositivity increased through the tumor development with highest expression in the late nodular stages. In KSIMM cells, IGF-I induced accumulation of both HIF alpha subunits. The induction suggests a translation mechanism as documented by cycloheximide chase experiment coupled with constant RNA levels as evaluated by quantitative real-time PCR. IGF-I-induced HIF alpha accumulation was followed by an increase in HIF function as assessed both by reporter gene assay and by induction of endogenous target gene expression (VEGF-A). Specific blockade of IGF-I receptor with alphaIR3 antibody or with picropodophyllin, a specific IGF-IR tyrosine kinase inhibitor, diminishes the basal and IGF-I-dependent induction of both HIF alpha congeners.
CONCLUSION: These novel findings show the coupling between the IGF and HIF signaling in KS and suggest a coordinated contribution by these pathways to the characteristic vascular phenotype of this tumor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16899596     DOI: 10.1158/1078-0432.CCR-05-2473

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  25 in total

Review 1.  Reprogramming of cellular metabolic pathways by human oncogenic viruses.

Authors:  John G Purdy; Micah A Luftig
Journal:  Curr Opin Virol       Date:  2019-11-22       Impact factor: 7.090

2.  Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.

Authors:  Xudong Tang; Qunzhou Zhang; Shihong Shi; Yun Yen; Xiangyong Li; Yuefei Zhang; Keyuan Zhou; Anh D Le
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

Review 3.  Effects of Post-translational Modifications on Membrane Localization and Signaling of Prostanoid GPCR-G Protein Complexes and the Role of Hypoxia.

Authors:  Anurag S Sikarwar; Anjali Y Bhagirath; Shyamala Dakshinamurti
Journal:  J Membr Biol       Date:  2019-09-04       Impact factor: 1.843

4.  The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains.

Authors:  Muzammel Haque; K G Kousoulas
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

5.  Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1alpha and HIF-2alpha.

Authors:  Donghoon Yoon; David V Okhotin; Bumjun Kim; Yulia Okhotina; Daniel J Okhotin; Galina Y Miasnikova; Adelina I Sergueeva; Lydia A Polyakova; Alexei Maslow; Yonggu Lee; Gregg L Semenza; Josef T Prchal; Victor R Gordeuk
Journal:  J Mol Med (Berl)       Date:  2010-02-08       Impact factor: 4.599

6.  Effects of oxygen tension and IGF-I on HIF-1α protein expression in mouse blastocysts.

Authors:  Jeong Yoon; Kyoung-Mi Juhn; Jin-Kyung Ko; San-Hyun Yoon; Yong Ko; Chul-Young Lee; Jin-Ho Lim
Journal:  J Assist Reprod Genet       Date:  2012-12-12       Impact factor: 3.412

7.  Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.

Authors:  Rachel A Bender Ignacio; Jeannette Y Lee; Michelle A Rudek; Dirk P Dittmer; Richard F Ambinder; Susan E Krown
Journal:  J Acquir Immune Defic Syndr       Date:  2016-05-01       Impact factor: 3.731

8.  Regulation of HIF-1 alpha by the proprotein convertases furin and PC7 in human squamous carcinoma cells.

Authors:  Jian Fu; Jirong Zhang; Yulan Gong; Courtney Lyons Testa; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2014-01-16       Impact factor: 4.784

9.  The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1α and causes its degradation via the proteasome pathway.

Authors:  Muzammel Haque; Konstantin G Kousoulas
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

10.  Hypoxia decreases insulin signaling pathways in adipocytes.

Authors:  Claire Regazzetti; Pascal Peraldi; Thierry Grémeaux; Rosanna Najem-Lendom; Issam Ben-Sahra; Mireille Cormont; Frédéric Bost; Yannick Le Marchand-Brustel; Jean-François Tanti; Sophie Giorgetti-Peraldi
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.